T-Day 5mg Tablets (Levocetirizine) – Antihistamine Tab

Drug Class: Third-Generation Antihistamine (H1 Receptor Antagonist) | Form: Oral Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered

What is T-Day 5mg Tablet?

T-Day 5mg contains Levocetirizine Dihydrochloride — a third-generation, potent and highly selective antihistamine that provides powerful allergy relief with significantly less sedation than first-generation antihistamines like Chlorpheniramine. Levocetirizine is the active R-enantiomer of Cetirizine — retaining full antihistamine potency at half the dose while producing even lower CNS penetration and sedation than its parent compound. It works by selectively and competitively blocking peripheral histamine H1 receptors — preventing histamine from triggering the sneezing, itching, runny nose, watery eyes, and skin reactions that characterise allergic conditions. A single once-daily evening dose provides 24-hour allergy symptom control — making T-Day 5mg one of the most convenient and effective antihistamine options for both seasonal allergic rhinitis (موسمی الرجی) and chronic urticaria (دائمی چھپاکی) in adults and children above 6 years.

What is T-Day 5mg Used For?

• Seasonal allergic rhinitis (hay fever) — sneezing, runny nose, nasal itching, and watery eyes caused by pollen and seasonal allergens (موسمی ناک کی الرجی)
• Perennial allergic rhinitis — year-round nasal allergy symptoms caused by dust mites, pet dander, and mould (سالانہ ناک کی الرجی)
• Chronic idiopathic urticaria — persistent itchy hives and skin welts of unknown cause (دائمی چھپاکی)
• Allergic conjunctivitis — itchy, red, watery eyes caused by allergen exposure (آنکھوں کی الرجی)
• Skin allergy symptoms — generalised itching, rash, and angioedema associated with allergic reactions (جلد کی الرجی)
• Insect bite reactions — local and systemic allergic responses to insect stings and bites
• Food allergy symptoms — relief of mild skin and nasal symptoms associated with food hypersensitivity reactions

How Does T-Day 5mg Work?

Selective Peripheral H1 Receptor Blockade: When the body encounters an allergen — pollen, dust, pet dander, or food — sensitised mast cells and basophils release histamine into surrounding tissues. Histamine binds to H1 receptors located on blood vessel walls, mucous membrane cells, sensory nerve endings, and smooth muscle — triggering the classic allergic response: vasodilation and increased capillary permeability causing redness and swelling, stimulation of sensory nerve endings causing itching and sneezing, increased mucus secretion causing runny nose and watery eyes, and smooth muscle contraction in the airways and gut. Levocetirizine selectively and competitively occupies H1 receptors — blocking histamine binding and preventing all these downstream allergic effects simultaneously with a single once-daily dose.

Superior Receptor Selectivity and Potency: As the active R-enantiomer of Cetirizine, Levocetirizine has approximately twice the H1 receptor binding affinity of Cetirizine — meaning it achieves complete and sustained H1 blockade at a lower total dose. Its exceptionally high receptor selectivity means it has minimal affinity for other receptor types — producing far fewer anticholinergic side effects (dry mouth, urinary retention, constipation) than first-generation antihistamines like Chlorpheniramine or Promethazine.

Low CNS Penetration — Reduced Sedation: Levocetirizine has low lipophilicity — meaning it crosses the blood-brain barrier poorly and acts primarily on peripheral H1 receptors in the nose, eyes, and skin rather than central H1 receptors in the brain. This peripheral selectivity is why T-Day 5mg produces significantly less sedation than first-generation antihistamines — making it suitable for daytime use in most patients while still maintaining the once-daily evening dosing recommendation that optimises peak drug levels during overnight allergen exposure.

Dosage and Administration

⚠️ Always take exactly as prescribed by your doctor. Never exceed the recommended dose. Dose reduction is required in patients with kidney disease.

Critical Dosing Rules:

• Evening dosing is strongly recommended — allergen exposure and histamine release are typically highest during nighttime and early morning hours; evening dosing ensures peak Levocetirizine blood levels during this vulnerable period while minimising any daytime sedation
• Kidney function must be assessed before prescribing in patients with known renal impairment — Levocetirizine is primarily renally excreted and accumulates in kidney disease; dose reduction or extended dosing intervals are required based on eGFR
• Do not give to children under 6 years in tablet form — use age-appropriate liquid Levocetirizine formulations for younger children
• Elderly patients may require dose reduction — reduced kidney clearance in elderly patients increases Levocetirizine blood levels and sedation risk
• Not recommended for patients with end-stage kidney disease on dialysis

How to Take:

• Swallow the tablet whole with a full glass of water
• May be taken with or without food — food does not significantly affect absorption
• Take at the same time each evening for consistent 24-hour allergy control
• If a dose is missed, take it as soon as remembered the same evening — skip if it is the next day; never double the dose
• Avoid alcohol during treatment — enhances sedation risk

Active Ingredients

Who Should NOT Take T-Day 5mg?

Do not take if you:

• Are allergic to Levocetirizine, Cetirizine, Hydroxyzine, or any piperazine-derived antihistamine
• Have end-stage kidney disease (eGFR below 10 mL/min) or are on dialysis
• Have hereditary galactose intolerance — if tablet contains lactose
• Are under 6 years of age in tablet form

Always consult your doctor before taking T-Day if you have:

• Any degree of kidney disease (گردے کی بیماری) — dose adjustment based on eGFR is essential
• Liver disease (جگر کی بیماری) — monitor with prolonged use
• Epilepsy or history of seizures (مرگی) — antihistamines can affect seizure threshold
• Enlarged prostate or urinary difficulties — mild anticholinergic effects may worsen urinary flow
• Are pregnant — limited human safety data; use only when clearly necessary under medical supervision
• Are breastfeeding — Levocetirizine passes into breast milk; consult your doctor
• Are elderly — reduced kidney clearance increases sedation risk; start at lower dose if needed
• Are taking CNS depressants, sedatives, or alcohol — additive sedation risk
• Have a job or activity requiring high levels of alertness — assess individual sedation response before driving

Side Effects

Common Side Effects:

• Drowsiness or sedation — less common than first-generation antihistamines but can occur particularly in sensitive patients or at higher doses; avoid driving until individual response is established
• Dry mouth — mild; less pronounced than first-generation antihistamines; drink water frequently
• Headache — mild and usually temporary
• Fatigue or tiredness — usually mild; more common in the first few days of treatment
• Nausea or mild stomach discomfort — mild and usually self-limiting
• Nasopharyngitis — mild nose and throat irritation; antihistamine class effect

Serious Side Effects — Stop Taking and Seek Medical Help Immediately:

• Severe allergic reaction — swelling of face, lips, tongue or throat, difficulty breathing, widespread rash or hives — paradoxically rare but possible hypersensitivity to Levocetirizine itself (یہ طبی ہنگامی صورتحال ہے)
• Severe sedation or CNS depression — extreme drowsiness, confusion, or loss of coordination — particularly in patients with kidney impairment taking standard doses without adjustment or when combined with CNS depressants
• Acute urinary retention — complete inability to urinate — rare anticholinergic effect; particularly in elderly men with enlarged prostate
• Severe liver toxicity — yellowing of skin or eyes (یرقان), dark urine, extreme fatigue — rare but reported; stop immediately and seek medical attention
• Seizures — rare; antihistamines can lower seizure threshold in predisposed patients; seek immediate neurological evaluation
• Visual disturbances — blurred vision or visual changes — mild anticholinergic effect; report to doctor if persistent or worsening
• Angioedema — sudden swelling of deeper skin layers of face, lips, tongue, or throat — rare but serious; seek emergency care immediately

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister pack until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date printed on the pack

Frequently Asked Questions (FAQs)

Q: Can I drive after taking T-Day 5mg? T-Day is significantly less sedating than older antihistamines — however individual responses vary; assess your own alertness and reaction time before driving or operating machinery, particularly in the first few days of treatment or after dose changes.

Q: Why is evening dosing recommended for T-Day 5mg? Allergen exposure and histamine release are typically highest at night and in the early morning — taking T-Day in the evening ensures peak drug levels during these high-exposure hours while any mild sedation coincides with sleep rather than daytime activities.

Q: How is T-Day 5mg different from Cetirizine? Levocetirizine is the active half of Cetirizine — achieving equivalent antihistamine effect at half the dose with greater H1 receptor selectivity, lower anticholinergic side effects, and slightly less sedation than standard Cetirizine 10mg.

Q: Can T-Day 5mg be taken every day for long-term allergy control? Yes — Levocetirizine is suitable for ongoing daily allergy management; however long-term use should be reviewed periodically by your doctor to confirm continued appropriateness, check kidney function, and assess whether dose adjustment is needed.

Medical Disclaimer: This information is for general awareness only and does not replace advice from your doctor or pharmacist. Always take T-Day 5mg exactly as prescribed and inform your doctor of all other medicines you are currently taking. Patients with kidney disease must not take standard doses without medical assessment and dose adjustment.